Higher percentages of apoptotic CD4+ and CD8+ were observed in the NHL patients compared with the normal controls (median = 27.5% vs. 0.1% and 10.5% vs. 0.1%, respectively; p < 0.01). This evidence concerns the gene CD8A and non-Hodgkin lymphoma.